Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Atema, A
Sponsors say the bill would improve public health and reduce the costs that government programs such as Medicaid incur for treating cancer, heart disease and other smoking-related illnesses
Despite regulatory pressures, BAT demonstrates robust cash generation and a promising strategic pivot, making it an attractive BUY opportunity with a three-year upside of 41.4% (including dividend yields) from its current price of 32.27 for a target price of 38.18
No adverse events or other clinical concerns were observed in this study
These can help you save even more on your purchase
US$ 23.43
US$ 29.80
US$ 21.05
US$ 27.21
US$ 27.82
